Use of electron-beam sterilized hemodialysis membranes and risk of thrombocytopenia

JAMA

Volumn 306, Issue 15, 2011, Pages 1679-1687

  Kiaii, Mercedeh ^a   Djurdjev, Ognjenka ^b   Farah, Myriam ^a   Levin, Adeera ^a,b   Jung, Beverly ^a   MacRae, Jennifer ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b British Columbia Provincial Renal Agency   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

POLYSULFONE;

ADULT; AGE; AGED; ARTICLE; CANADA; COHORT ANALYSIS; CONTROLLED STUDY; DIALYSIS MEMBRANE; ELECTRON BEAM; ELECTRON BEAM STERILIZED DIALYZER; FEMALE; GENDER; HEMODIALYSIS; HUMAN; KIDNEY DISEASE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PRIORITY JOURNAL; RADIATION STERILIZATION; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT DURATION;

EID: 80054736159     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.1499     Document Type: Article

References (17)

1. Uhlenbusch-Korwer I. Biocompatibility characteristics of dialyzers and hemofilters. In: Vienken J, ed. Understanding Membranes and Dialysers. Lengerich, Germany: Pabst Science Publishers; 2004:265-266.
2. Lindsay RM, Prentice CRM, Davidson JF, Burton JA, McNicol GP. Haemostatic changes during dialysis associated with thrombus formation on dialysis membranes. Br Med J. 1972;4(5838):454-458.
3. Shintani H, Nakamura A. Formation of 4,4′-methylenedianiline in polyurethane potting materials by either gamma-ray or autoclave sterilization. J Biomed Mater Res. 1991;25(10):1275-1286.
4. Daugirdas JT, Ing TS. First-use reactions during hemodialysis: a definition of subtypes. Kidney Int Suppl. 1988;24:S37-S43. (Pubitemid 18078132)
5. Milburn JA, Cassar K, Ford I, Fluck N, Brittenden J. Prothrombotic changes in platelet, endothelial and coagulation function following hemodialysis. Int J Artif Organs. 2011;34(3):280-287.
6. Hakim RM. Complement activation by biomaterials. Cardiovasc Pathol. 1993;2(3):187S-197S.
7. Gawas MP, Mujais SK, Schmidt B, Gurland HJ. Platelet-leukocyte aggregation during hemodialysis. Kidney Int. 1994;46(2):489-495. (Pubitemid 24253058)
8. Lotner GZ, Lynch JM, Betz SJ, Henson PM. Human neutrophil-derived platelet activating factor. J Immunol. 1980;124(2):676-684. (Pubitemid 10146335)
9. Lindsay RM, Prentice CRM, Burton JA, Ferguson D, Kennedy AC. The role of the platelet-dialysis membrane interaction in thrombus formation and blood loss during hemodialysis. Trans Am Soc Artif Intern Organs. 1973;19:487-491.
10. Hakim RM, Schafer AI. Hemodialysis-associated platelet activation and thrombocytopenia. Am J Med. 1985;78(4):575-580. (Pubitemid 15091280)
11. Lindsay RM, Prentice CRM, Ferguson D, Muir WM, McNicol GP. A method for the measurement of platelet adhesiveness by use of dialysis membranes in a test-cell. Br J Haematol. 1973;24(3):377-389.
12. Gavioli G, Gennari M, Bruns S. Methods of sterilization and their effects on membrane performance and safety. In: Ronco C, La Greca G, eds. Hemodialysis Technology. Basel, Switzerland: Karger Publishers; 2002:80.
13. Gritters-van den Oever M, Schoorl M, Schoorl M, et al. The role of the extracorporeal circuit in the trapping and degranulation of platelets. Blood Purif. 2009;28(3):253-259.
14. Clark WR, Gao D. Properties of membranes used for hemodialysis therapy. Semin Dial. 2002;15(3):191-195. (Pubitemid 41765930)
15. Post JB. Thrombocytopenia associated with use of a biocompatible hemodialysis membrane: a case report. Am J Kidney Dis. 2010;55(6):e25-e28.
16. Olafiranye F, Kyaw W, Olafiranye O. Resolution of dialyzer membrane-associated thrombocytopenia with use of cellulose triacetate membrane: a case report. Case Report Med. 2011;2011:134295.
17. Posadas MA, Hahn D, Schleuter W, Paparello J. Thrombocytopenia associated with dialysis treatments. Hemodial Int. 2011;15(3):416-423.